B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26409285.
- Also identified by DOI 10.1093/cid/civ614 and PMC identifier 4583574.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The protective role of B cells and humoral immune responses in tuberculosis infection has been regarded as inferior to cellular immunity directed to the intracellular pathogen Mycobacterium tuberculosis. However, B-cell-mediated immune responses in tuberculosis have recently been revisited in the context of B-cell physiology and antigen presentation. We discuss in this review the diverse functions of B cells in tuberculosis, with a focus on their biological and clinical relevance to progression of active disease. We also present the peptide microarray platform as a promising strategy to discover unknown antigenic targets of M. tuberculosis that could contribute to the better understanding of epitope focus of the humoral immune system against M. tuberculosis.
Medical subject headings
- B-Lymphocytes
- Mycobacterium tuberculosis
- Tuberculosis